Your Article Summary
B-type Natriuretic Peptide to Guide Therapy of Patent Ductus Arteriosus
BMJ - ADC - Fetal and Neonatal, 11/06/08
Attridge JT et al. - BNP-guided therapy reduced the number of primary INDO doses. There was no increase in PDA persistence or associated morbidity.
Related Articles
Two-Stage Surgical Repair for Truncus Arteriosus with Unilateral Absence of the Left Proximal Pulmonary Artery: Translocation of the Left Pulmonary Artery to the Right Pulmonary Artery
Journal of Cardiac Surgery, 10/22/09
Relevance Score: 66%
N-terminal-Pro-B-Type Natriuretic Peptide in Premature Patent Ductus Arteriosus: A Physiologic Biomarker, But Is It a Clinical Tool
Pediatric Cardiology, 11/10/09
Relevance Score: 65%
Oral Ibuprofen and Ductus Arteriosus Closure in Full-Term Neonates: A Prospective Case-Control Study
Pediatric Cardiology, 10/30/09
Relevance Score: 64%
Microcirculation in Preterm Infants: Profound Effects of Patent Ductus Arteriosus
The Journal of Pediatrics, 10/23/09
Relevance Score: 64%
Successful Two-Stage Correction of Ventricular Septal Defect and Patent Ductus Arteriosus in a Patient with Fixed Pulmonary Hypertension
Pediatric Cardiology, 10/22/09
Relevance Score: 64%
Today in Pediatric Cardiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Late-Onset Pulmonary Arterial Hypertension After a Successful Atrial or Arterial Switch Procedure for Transposition of the Great Arteries
Pediatric Cardiology, 12/19/09
Left Hemitruncus Associated with Tetralogy of Fallot: Fetal Diagnosis and Postnatal Echocardiographic and Cardiac Computed Tomographic Confirmation
Pediatric Cardiology, 12/19/09
Examining the Cardiac NK-2 Genes in Early Heart Development
Pediatric Cardiology, 12/19/09

See Latest Articles